Developer docs
API playgroundTry for free, no card

Search company profiles

Inseption Group

Full company profile

uuid000bn8s

Namestring
Inseption Group
Legal namestring
inSeption Group, LLC
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Inseption Group is a privately held, Pennsylvania-based clinical outsourcing organization serving emerging and mid-sized biotechnology and pharmaceutical sponsors. Founded in 2011 (per company history) and headquartered in Audubon, PA, the firm operates with 51-100 employees and runs a professional services model organized around three primary engagement constructs: Functional Service Provider (FSP) where embedded personnel become extensions of sponsor teams; Full-Service clinical trial outsourcing; and Deliverables-Based projects for defined outputs such as protocols, CSRs, IBs, audits and regulatory documents. Core functional coverage spans Clinical Operations, Site Management and Clinical Monitoring, Data Management, Drug Safety, Quality Assurance and Auditing, Medical Monitoring, Medical Writing and Quality Control, Biostatistics, Trial Master File Management, Regulatory Operations, Regulatory Affairs, and Contracts.

Underlying processes are anchored by the proprietary Cooperativity Program, a structured onboarding, mentoring and performance management framework designed to maintain low staff turnover (the firm reports <6% attrition overall and 0% turnover across a decade-long FSP engagement). The offering is differentiated along therapeutic depth rather than proprietary software: Inseption maintains specialized practices in rare/orphan disease, oncology (including CAR-T), neurodegenerative disorders, cell therapy, and gene therapy. A Clinical Trial Rescue solution and an IND planning/submission service address earlier-stage and troubled-program use cases, and a Strategic Consulting layer sits above functional delivery.

Revenue mechanics are quote-based across all three engagement models; pricing is not publicly disclosed. The go-to-market is sales-led and consultative, with enterprise field sales targeting sponsors directly, supported by content marketing (thought leadership articles, webinars, video interviews), an active LinkedIn presence, and PR. The company reports 100% of business from referrals or repeat clients and a majority of revenue from emerging and mid-sized biotech. Strategic positioning emphasizes transparency, talent stability, and therapeutic expertise as alternatives to large-volume commoditized CRO relationships.

Short descriptiontext

Inseption Group is a privately held clinical outsourcing organization serving emerging and mid-sized biotech and pharma sponsors. It provides FSP, full-service and deliverables-based clinical research engagements across rare disease, oncology, cell and gene therapy, and neurodegenerative programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAudubon, United States
HQ citystring
Audubon
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, clinical outsourcing solutions, functional service provider, biotech regulatory consulting, drug safety pharmacovigilance
Industry4 codes
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Consulting Services8742
Product category
Clinical Research Services (Contract Research Organization)
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Outsourcing Services
TypeProfessional Services
Description

Full-service, FSP (Functional Service Provider), and deliverables-based clinical research services. Revenue is generated through professional service engagements with biotech and pharma companies across various engagement models including full-service outsourcing, functional service provider arrangements, and project-based deliverables.

inseptiongroup.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

InSeption Group is a clinical outsourcing organization that provides biotech and pharmaceutical sponsors with outsourced clinical research services across the full clinical trial lifecycle. The company delivers these services through three engagement models — Functional Service Provider (FSP), Full Service, and Deliverables-Based Outsourcing — covering functional areas including Clinical Operations, Site Management & Clinical Monitoring, Data Management, Drug Safety, Quality Assurance, Medical Monitoring, Medical Writing, Biostatistics, TMF Management, Regulatory Operations, Regulatory Affairs, and Contracts, with concentrated therapeutic expertise in rare/orphan diseases, oncology, neurodegenerative disorders, cell therapy, and gene therapy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • <6% employee attrition rate
+2 more records
Product overview1 text field

Inseption Group is a clinical outsourcing organization offering a comprehensive suite of services across the clinical research lifecycle. The company provides functional services (Clinical Operations, Site Management, Data Management, Drug Safety, Quality Assurance, Medical Monitoring, Medical Writing, Biostatistics, Regulatory Operations, Regulatory Affairs, and Contracts) through multiple engagement models including Functional Service Provider (FSP), Full Service, and Deliverables-Based Outsourcing. The portfolio includes specialized solutions for complex needs such as Clinical Trial Rescue Support, Investigational New Drug Applications, and Strategic Consulting, supported by the Cooperativity Program for structured onboarding. The company focuses on therapeutic areas including Rare/Orphan Disease, Oncology, Neurodegenerative Disorders, Cell Therapy, and Gene Therapy.

Product and service25 records
1Functional Service Provider (FSP)
CategoryEngagement Model / Outsourcing Solution
Description

Embedded professional model providing clinical research experts who become extensions of sponsor teams, offering structure, continuity, and leadership within client organizations.

2Full Service Clinical Outsourcing
CategoryEngagement Model / Outsourcing Solution
Description

Comprehensive clinical trial outsourcing solution providing specialized talent, under <6% employee attrition, and transparent cost structures for end-to-end trial execution.

3Deliverables-Based Outsourcing
CategoryEngagement Model / Outsourcing Solution
Description

Project-based outsourcing for specific clinical deliverables such as protocols, CSRs, IBs, audits, and regulatory documents.

4Clinical Trial Rescue Support
CategoryOutsourcing Solution
Description

Strategic reinforcement services that address trial failures through targeted scaffolding rather than complete program overhaul.

5Investigational New Drug (IND) Applications
CategoryRegulatory Solution
Description

IND planning, authoring, and submission services including strategic planning, regulatory pathway evaluation, and FDA communication for first-in-human trials.

6Strategic Consulting
CategoryConsulting Service
Description

Advisory services for clinical development strategy, partner selection, and operational excellence.

7Cooperativity Program
CategoryEngagement Program
Description

Structured onboarding, mentoring, and performance management program for integrating embedded professionals into client teams.

8Pre-IND Submission Training
CategoryTraining Service
Description

Training on the IND process, FDA expectations, strategic tips, and practical preparation tools for first-in-human trials.

9Clinical Operations
CategoryFunctional Service
Description

Expert management and oversight of clinical trial activities including project management, operational planning, and cross-functional coordination.

10Site Management & Clinical Monitoring
CategoryFunctional Service
Description

Comprehensive site management, end-to-end clinical monitoring, and monitoring oversight services.

11Data Management
CategoryFunctional Service
Description

Collection, validation, and management of clinical trial data to ensure accuracy and regulatory compliance.

12Drug Safety / Pharmacovigilance
CategoryFunctional Service
Description

Pharmacovigilance and drug safety operations including adverse event reporting and safety monitoring.

13Quality Assurance & Auditing
CategoryFunctional Service
Description

Quality assurance services including clinical and vendor audits, gap assessments, CAPA plans, and inspection readiness support.

14Medical Monitoring
CategoryFunctional Service
Description

Medical oversight of clinical trials ensuring patient safety and protocol compliance.

15Medical Writing & Quality Control
CategoryFunctional Service
Description

Regulatory and medical documentation including protocols, CSRs, IBs, narratives, and IND/NDA module content with quality control.

16Biostatistics
CategoryFunctional Service
Description

Statistical analysis services including SAP development and statistical support for clinical programs.

17Trial Master File (TMF) Management
CategoryFunctional Service
Description

TMF structure, management, health checks, remediation, and inspection readiness.

18Regulatory Operations
CategoryFunctional Service
Description

Technical regulatory submissions including eCTD submissions to the FDA through the ESG Gateway.

19Regulatory Affairs
CategoryFunctional Service
Description

Regulatory strategy, FDA meeting support, briefing documents, and navigation of regulatory requirements.

20Contracts
CategoryFunctional Service
Description

Contract development and vendor oversight services for clinical trial programs.

21Rare/Orphan Disease Clinical Expertise
CategoryTherapeutic Expertise Area
Description

Specialized expertise in rare and orphan disease clinical trials.

22Oncology Clinical Expertise
CategoryTherapeutic Expertise Area
Description

Specialized expertise in oncology clinical trials including CAR-T and cell therapy.

23Neurodegenerative Disorders Clinical Expertise
CategoryTherapeutic Expertise Area
Description

Specialized expertise in neurodegenerative disorder clinical trials.

24Cell Therapy Clinical Expertise
CategoryTherapeutic Expertise Area
Description

Specialized expertise in cell therapy clinical trials including autologous cell therapy.

25Gene Therapy Clinical Expertise
CategoryTherapeutic Expertise Area
Description

Specialized expertise in gene therapy clinical trials.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-07
Description

inSeption Group has partnered with the Pennsylvania Biotechnology Center (PABC) as the exclusive outsourcing partner for the PABC and B+Labs community. This strategic collaboration provides crucial strategic guidance and support to early-stage biotech companies in the PABC ecosystem, helping them navigate the complexities of early trial planning and development. The partnership aligns both organizations' missions to accelerate life sciences innovations and enhance support for emerging biotech companies, with inSeption delivering industry-leading expertise in clinical outsourcing.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-sized, scientifically focused CRO with a comparable model of serving small-to-mid biotech and pharma sponsors with full-service clinical trial execution across multiple therapeutic areas. Medpace competes for many of the same emerging and mid-sized biotech mandates InSeption targets.

TypeDirect peer
Description

Mid-sized CRO providing full-service clinical research, biostatistics, and regulatory services to emerging and mid-sized biopharma. Closely comparable in size, sponsor profile, and service breadth.

TypeDirect peer
Description

Mid-sized CRO concentrating on complex therapeutic areas including CNS, oncology, and rare diseases for small and mid-sized biopharma. Comparable to InSeption in therapeutic focus and mid-market sponsor positioning.

TypeBroad incumbent
Description

Largest global CRO with comprehensive FSP, full-service, and technology-enabled offerings. Competes with InSeption for biotech outsourcing mandates but at vastly larger scale and with proprietary technology (e.g., E360, RBQM).

TypeBroad incumbent
Description

Large global CRO with biopharma services and FSP offerings. While much larger, Syneos' commercialized FSP model overlaps with InSeption's positioning for biotech sponsor embedded teams.

TypeDirect peer
Description

Specialty CRO focused on small and mid-sized biopharma, with deep expertise in rare disease, oncology, neurology, and cell/gene therapy — a near-identical therapeutic profile to InSeption. Direct competitor for emerging biotech FSP and full-service engagements.

TypeEmerging player
Description

Mid-sized CRO focused on Asia-Pacific and global clinical operations for biotech sponsors, with growing presence in cell/gene therapy and oncology trials — therapeutic areas that overlap with InSeption's specialization.

TypeBroad incumbent
Description

Top-tier global CRO offering full-service and FSP across all therapeutic areas. Competes for emerging biotech work but serves a much broader sponsor base including large pharma; offers proprietary technology platforms InSeption does not.

TypeEmerging player
Description

Data-focused clinical research organization providing biostatistics, statistical programming, data management, and regulatory services to biopharma. Partial overlap with InSeption's data management and biostatistics offerings, particularly for FSP engagements.

TypeDirect peer
Description

Mid-sized CRO with FSP and full-service offerings targeted at small-to-mid biotech sponsors, with overlapping functional service categories (data management, biostatistics, regulatory, clinical operations).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Inseption Group

Clinical Research Services (Contract Research Organization)inseptiongroup.com

Inseption Group is a privately held clinical outsourcing organization serving emerging and mid-sized biotech and pharma sponsors. It provides FSP, full-service and deliverables-based clinical research engagements across rare disease, oncology, cell and gene therapy, and neurodegenerative programs.

What Inseption Group does

Inseption Group is a privately held, Pennsylvania-based clinical outsourcing organization serving emerging and mid-sized biotechnology and pharmaceutical sponsors. Founded in 2011 (per company history) and headquartered in Audubon, PA, the firm operates with 51-100 employees and runs a professional services model organized around three primary engagement constructs: Functional Service Provider (FSP) where embedded personnel become extensions of sponsor teams; Full-Service clinical trial outsourcing; and Deliverables-Based projects for defined outputs such as protocols, CSRs, IBs, audits and regulatory documents. Core functional coverage spans Clinical Operations, Site Management and Clinical Monitoring, Data Management, Drug Safety, Quality Assurance and Auditing, Medical Monitoring, Medical Writing and Quality Control, Biostatistics, Trial Master File Management, Regulatory Operations, Regulatory Affairs, and Contracts.

Underlying processes are anchored by the proprietary Cooperativity Program, a structured onboarding, mentoring and performance management framework designed to maintain low staff turnover (the firm reports <6% attrition overall and 0% turnover across a decade-long FSP engagement). The offering is differentiated along therapeutic depth rather than proprietary software: Inseption maintains specialized practices in rare/orphan disease, oncology (including CAR-T), neurodegenerative disorders, cell therapy, and gene therapy. A Clinical Trial Rescue solution and an IND planning/submission service address earlier-stage and troubled-program use cases, and a Strategic Consulting layer sits above functional delivery.

Revenue mechanics are quote-based across all three engagement models; pricing is not publicly disclosed. The go-to-market is sales-led and consultative, with enterprise field sales targeting sponsors directly, supported by content marketing (thought leadership articles, webinars, video interviews), an active LinkedIn presence, and PR. The company reports 100% of business from referrals or repeat clients and a majority of revenue from emerging and mid-sized biotech. Strategic positioning emphasizes transparency, talent stability, and therapeutic expertise as alternatives to large-volume commoditized CRO relationships.

Inseption Group firmographics

Firmographics
Name
Inseption Group
Legal name
inSeption Group, LLC
Website
https://inseptiongroup.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
Inseption Group is a privately held clinical outsourcing organization serving emerging and mid-sized biotech and pharma sponsors. It provides FSP, full-service and deliverables-based clinical research engagements across rare disease, oncology, cell and gene therapy, and neurodegenerative programs.
Ownership category
akta.pro rank

Inseption Group industry classification

Industry
Product category
Clinical Research Services (Contract Research Organization)
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Clinical research services
  • Clinical outsourcing solutions
  • Functional service provider
  • Biotech regulatory consulting
  • Drug safety pharmacovigilance

Where Inseption Group is headquartered

Location

Headquarters

HQ city
Audubon
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Inseption Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Outsourcing Services: Full-service, FSP (Functional Service Provider), and deliverables-based clinical research services. Revenue is generated through professional service engagements with biotech and pharma companies across various engagement models including full-service outsourcing, functional service provider arrangements, and project-based deliverables.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Inseption Group product offering

Product offering

Core offering

InSeption Group is a clinical outsourcing organization that provides biotech and pharmaceutical sponsors with outsourced clinical research services across the full clinical trial lifecycle. The company delivers these services through three engagement models — Functional Service Provider (FSP), Full Service, and Deliverables-Based Outsourcing — covering functional areas including Clinical Operations, Site Management & Clinical Monitoring, Data Management, Drug Safety, Quality Assurance, Medical Monitoring, Medical Writing, Biostatistics, TMF Management, Regulatory Operations, Regulatory Affairs, and Contracts, with concentrated therapeutic expertise in rare/orphan diseases, oncology, neurodegenerative disorders, cell therapy, and gene therapy.

Product overview

Inseption Group is a clinical outsourcing organization offering a comprehensive suite of services across the clinical research lifecycle. The company provides functional services (Clinical Operations, Site Management, Data Management, Drug Safety, Quality Assurance, Medical Monitoring, Medical Writing, Biostatistics, Regulatory Operations, Regulatory Affairs, and Contracts) through multiple engagement models including Functional Service Provider (FSP), Full Service, and Deliverables-Based Outsourcing. The portfolio includes specialized solutions for complex needs such as Clinical Trial Rescue Support, Investigational New Drug Applications, and Strategic Consulting, supported by the Cooperativity Program for structured onboarding. The company focuses on therapeutic areas including Rare/Orphan Disease, Oncology, Neurodegenerative Disorders, Cell Therapy, and Gene Therapy.

Differentiator

Problem solved

Functional benefit

Products and services

  • Functional Service Provider (FSP) Embedded professional model providing clinical research experts who become extensions of sponsor teams, offering structure, continuity, and leadership within client organizations.
  • Full Service Clinical Outsourcing Comprehensive clinical trial outsourcing solution providing specialized talent, under <6% employee attrition, and transparent cost structures for end-to-end trial execution.
  • Deliverables-Based Outsourcing Project-based outsourcing for specific clinical deliverables such as protocols, CSRs, IBs, audits, and regulatory documents.
  • Clinical Trial Rescue Support Strategic reinforcement services that address trial failures through targeted scaffolding rather than complete program overhaul.
  • Investigational New Drug (IND) Applications IND planning, authoring, and submission services including strategic planning, regulatory pathway evaluation, and FDA communication for first-in-human trials.
  • Strategic Consulting Advisory services for clinical development strategy, partner selection, and operational excellence.
  • Cooperativity Program Structured onboarding, mentoring, and performance management program for integrating embedded professionals into client teams.
  • Pre-IND Submission Training Training on the IND process, FDA expectations, strategic tips, and practical preparation tools for first-in-human trials.
  • Clinical Operations Expert management and oversight of clinical trial activities including project management, operational planning, and cross-functional coordination.
  • Site Management & Clinical Monitoring Comprehensive site management, end-to-end clinical monitoring, and monitoring oversight services.
  • Data Management Collection, validation, and management of clinical trial data to ensure accuracy and regulatory compliance.
  • Drug Safety / Pharmacovigilance Pharmacovigilance and drug safety operations including adverse event reporting and safety monitoring.
  • Quality Assurance & Auditing Quality assurance services including clinical and vendor audits, gap assessments, CAPA plans, and inspection readiness support.
  • Medical Monitoring Medical oversight of clinical trials ensuring patient safety and protocol compliance.
  • Medical Writing & Quality Control Regulatory and medical documentation including protocols, CSRs, IBs, narratives, and IND/NDA module content with quality control.
  • Biostatistics Statistical analysis services including SAP development and statistical support for clinical programs.
  • Trial Master File (TMF) Management TMF structure, management, health checks, remediation, and inspection readiness.
  • Regulatory Operations Technical regulatory submissions including eCTD submissions to the FDA through the ESG Gateway.
  • Regulatory Affairs Regulatory strategy, FDA meeting support, briefing documents, and navigation of regulatory requirements.
  • Contracts Contract development and vendor oversight services for clinical trial programs.
  • Rare/Orphan Disease Clinical Expertise Specialized expertise in rare and orphan disease clinical trials.
  • Oncology Clinical Expertise Specialized expertise in oncology clinical trials including CAR-T and cell therapy.
  • Neurodegenerative Disorders Clinical Expertise Specialized expertise in neurodegenerative disorder clinical trials.
  • Cell Therapy Clinical Expertise Specialized expertise in cell therapy clinical trials including autologous cell therapy.
  • Gene Therapy Clinical Expertise Specialized expertise in gene therapy clinical trials.

Quantifiable outcome

  • <6% employee attrition rate
  • +2 more outcomes

Companies that use Inseption Group

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Inseption Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Inseption Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Pennsylvania Biotechnology Center (PABC)coreStrategic or Co-development Partner · 7 January 2025inSeption Group has partnered with the Pennsylvania Biotechnology Center (PABC) as the exclusive outsourcing partner for the PABC and B+Labs community. This strategic collaboration provides crucial strategic guidance and support to early-stage biotech companies in the PABC ecosystem, helping them navigate the complexities of early trial planning and development. The partnership aligns both organizations' missions to accelerate life sciences innovations and enhance support for emerging biotech companies, with inSeption delivering industry-leading expertise in clinical outsourcing.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Inseption Group competitors and assessment

Company assessment

Direct peers

  • Medpace: Mid-sized, scientifically focused CRO with a comparable model of serving small-to-mid biotech and pharma sponsors with full-service clinical trial execution across multiple therapeutic areas. Medpace competes for many of the same emerging and mid-sized biotech mandates InSeption targets.
  • Rho: Mid-sized CRO providing full-service clinical research, biostatistics, and regulatory services to emerging and mid-sized biopharma. Closely comparable in size, sponsor profile, and service breadth.
  • Worldwide Clinical Trials: Mid-sized CRO concentrating on complex therapeutic areas including CNS, oncology, and rare diseases for small and mid-sized biopharma. Comparable to InSeption in therapeutic focus and mid-market sponsor positioning.
  • Premier Research: Specialty CRO focused on small and mid-sized biopharma, with deep expertise in rare disease, oncology, neurology, and cell/gene therapy — a near-identical therapeutic profile to InSeption. Direct competitor for emerging biotech FSP and full-service engagements.
  • Clinipace Worldwide (now CRIO): Mid-sized CRO with FSP and full-service offerings targeted at small-to-mid biotech sponsors, with overlapping functional service categories (data management, biostatistics, regulatory, clinical operations).

Broad incumbents

  • IQVIA: Largest global CRO with comprehensive FSP, full-service, and technology-enabled offerings. Competes with InSeption for biotech outsourcing mandates but at vastly larger scale and with proprietary technology (e.g., E360, RBQM).
  • Syneos Health: Large global CRO with biopharma services and FSP offerings. While much larger, Syneos' commercialized FSP model overlaps with InSeption's positioning for biotech sponsor embedded teams.
  • ICON plc: Top-tier global CRO offering full-service and FSP across all therapeutic areas. Competes for emerging biotech work but serves a much broader sponsor base including large pharma; offers proprietary technology platforms InSeption does not.

Emerging players

  • Caidya (formerly dMed|Biophinix): Mid-sized CRO focused on Asia-Pacific and global clinical operations for biotech sponsors, with growing presence in cell/gene therapy and oncology trials — therapeutic areas that overlap with InSeption's specialization.
  • MMS Holdings: Data-focused clinical research organization providing biostatistics, statistical programming, data management, and regulatory services to biopharma. Partial overlap with InSeption's data management and biostatistics offerings, particularly for FSP engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Inseption Group social profiles

Digital presence

Inseption Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Inseption Group leadership team

Management profile

Number of profiles

Profiles3 records

Inseption Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Inseption Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inseption Group

What does Inseption Group do?

InSeption Group is a clinical outsourcing organization that provides biotech and pharmaceutical sponsors with outsourced clinical research services across the full clinical trial lifecycle. The company delivers these services through three engagement models — Functional Service Provider (FSP), Full Service, and Deliverables-Based Outsourcing — covering functional areas including Clinical Operations, Site Management & Clinical Monitoring, Data Management, Drug Safety, Quality Assurance, Medical Monitoring, Medical Writing, Biostatistics, TMF Management, Regulatory Operations, Regulatory Affairs, and Contracts, with concentrated therapeutic expertise in rare/orphan diseases, oncology, neurodegenerative disorders, cell therapy, and gene therapy.

Is Inseption Group a public or private company?

Inseption Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Inseption Group founded?

Inseption Group was founded in 2011. It employs 101 to 250 people.

Where is Inseption Group based?

Inseption Group is headquartered in Audubon, United States, in the North America region.

How does Inseption Group make money?

One revenue line is on record: clinical Outsourcing Services.

Who are Inseption Group's main competitors?

Direct peers on record are Medpace, Rho, Worldwide Clinical Trials, Premier Research and Clinipace Worldwide (now CRIO). Broad incumbents are IQVIA, Syneos Health and ICON plc. Emerging players are Caidya (formerly dMed|Biophinix) and MMS Holdings.

Does Inseption Group have an API?

No public API is recorded for Inseption Group.

What industry is Inseption Group in?

Inseption Group's product category is Clinical Research Services (Contract Research Organization). Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales